Literature DB >> 25859071

Antimicrobial use and antimicrobial resistance in nosocomial pathogens at a tertiary care hospital in Pune.

Velu Nair1, Dinesh Sharma2, A K Sahni3, Naveen Grover4, S Shankar5, S S Jaiswal6, S S Dalal7, D R Basannar8, Vivek S Phutane9, Atul Kotwal10, G Gopal Rao11, Deepak Batura12, M D Venkatesh13, Tapan Sinha14, Sushil Kumar15, D P Joshi16.   

Abstract

BACKGROUND: Resistance to antimicrobial agents is emerging in wide variety of nosocomial and community acquired pathogens. Widespread and often inappropriate use of broad spectrum antimicrobial agents is recognized as a significant contributing factor to the development and spread of bacterial resistance. This study was conducted to gain insight into the prevalent antimicrobial prescribing practices, and antimicrobial resistance pattern in nosocomial pathogens at a tertiary care hospital in Pune, India.
METHODS: Series of one day cross sectional point prevalence surveys were carried out on four days between March and August 2014. All eligible in patients were included in the study. A structured data entry form was used to collect the data for each patient. Relevant samples were collected for microbiological examination from all the clinically identified hospital acquired infection cases.
RESULTS: 41.73% of the eligible patients (95% CI: 39.52-43.97) had been prescribed at least one antimicrobial during their stay in the hospital. Beta-lactams (38%) were the most prescribed antimicrobials, followed by Protein synthesis inhibitors (24%). Majority of the organisms isolated from Hospital acquired infection (HAI cases) were found to be resistant to the commonly used antimicrobials viz: Cefotaxime, Ceftriaxone, Amikacin, Gentamicin and Monobactams.
CONCLUSION: There is need to have regular antimicrobial susceptibility surveillance and dissemination of this information to the clinicians. In addition, emphasis on the rational use of antimicrobials, antimicrobial rotation and strict adherence to the standard treatment guidelines is very essential.

Entities:  

Keywords:  Antibiotic sensitivity; Antifungal sensitivity; Antimicrobial use; Hospital acquired infection; Microorganisms

Year:  2015        PMID: 25859071      PMCID: PMC4388980          DOI: 10.1016/j.mjafi.2014.12.024

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  10 in total

1.  Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.

Authors:  S K Fridkin; C D Steward; J R Edwards; E R Pryor; J E McGowan; L K Archibald; R P Gaynes; F C Tenover
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  An antibiotic policy to prevent emergence of resistant bacilli.

Authors:  P de Man; B A Verhoeven; H A Verbrugh; M C Vos; J N van den Anker
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

Review 3.  Development and spread of bacterial resistance to antimicrobial agents: an overview.

Authors:  F C Tenover
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

4.  Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002).

Authors:  R H Vander Stichele; M M Elseviers; M Ferech; S Blot; H Goossens
Journal:  J Antimicrob Chemother       Date:  2006-05-12       Impact factor: 5.790

5.  An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil.

Authors:  A S Levin; C M Mendes; S I Sinto; H S Sader; C R Scarpitta; E Rodrigues; N Sauaia; M Boulos
Journal:  Infect Control Hosp Epidemiol       Date:  1996-06       Impact factor: 3.254

6.  Prevalence of hospital-associated infections can be decreased effectively in developing countries.

Authors:  M Ogwang; D Paramatti; T Molteni; E Ochola; T R Okello; J C Ortiz Salgado; A Kayanja; C Greco; D Kizza; E Gondoni; J Okot; L Praticò; V Granata; A Filia; H Kellar Ayugi; D Greco
Journal:  J Hosp Infect       Date:  2013-05-01       Impact factor: 3.926

Review 7.  Reasons for the emergence of antibiotic resistance.

Authors:  F C Tenover; J E McGowan
Journal:  Am J Med Sci       Date:  1996-01       Impact factor: 2.378

8.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.

Authors:  S Handwerger; B Raucher; D Altarac; J Monka; S Marchione; K V Singh; B E Murray; J Wolff; B Walters
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

Review 9.  Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership.

Authors:  D A Goldmann; R A Weinstein; R P Wenzel; O C Tablan; R J Duma; R P Gaynes; J Schlosser; W J Martone
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

10.  The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.

Authors:  P Zarb; B Coignard; J Griskeviciene; A Muller; V Vankerckhoven; K Weist; Mm Goossens; S Vaerenberg; S Hopkins; B Catry; Dl Monnet; H Goossens; C Suetens
Journal:  Euro Surveill       Date:  2012-11-15
  10 in total
  2 in total

1.  Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan.

Authors:  Feras Darwish Elhajji; Ghaith M Al-Taani; Lana Anani; Sahar Al-Masri; Haneen Abdalaziz; Su'ad H Qabba'h; Abdel Qader Al Bawab; Michael Scott; David Farren; Fiona Gilmore; Ann Versporten; Herman Goossens; Mamoon A Aldeyab
Journal:  BMC Health Serv Res       Date:  2018-11-12       Impact factor: 2.655

2.  Predicting Healthcare-associated Infections: are Point of Prevalence Surveys data useful?

Authors:  Marco Golfera; Fabrizio Toscano; Gabriele Cevenini; Maria F DE Marco; Barbara R Porchia; Andrea Serafini; Emma Ceriale; Daniele Lenzi; Gabriele Messina
Journal:  J Prev Med Hyg       Date:  2022-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.